This Week in Science

The editor-in-chief of Science decries Pfizer's subpoena served on the New England Journal of Medicine. Pfizer is being sued by plaintiffs who say that Celebrex and Bextra cause cardiovascular and other injuries, and some of them may point to NEJM papers to back up their claims. Pfizer, then, wants to look through the confidential peer-reviews of those, saying the public has no interest in protecting the editorial process of a journal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.